TY - JOUR
T1 - New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents
AU - Thomas, K. D.
AU - Adhikari, Airody Vasudeva
AU - Chowdhury, Imran H.
AU - Sumesh, E.
AU - Pal, Nishith K.
PY - 2011/6
Y1 - 2011/6
N2 - Three new series of quinoline-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines were synthesized through multi-step reactions. The required intermediate, [1-(6-methoxy-2-methylquinolin-4-yl)-1H-1, 2,3-triazol-4-yl]methanol (2) was prepared by treating 4-azido-6-methoxy-2- methylquinoline (1) with propargyl alcohol. Three different series of compounds were synthesized from this intermediate. All the newly synthesized compounds were characterized by spectral and elemental analyses. The structure of 2 was confirmed by X-ray crystallographic study. Further, the title compounds were evaluated for their in vitro anti-bacterial activity against five different bacterial strains and antimycobacterial activity against Mycobacterium tuberculosis H37Rv, Mycobacterium smegmatis (ATCC 19420) and Mycobacterium fortuitum (ATCC 19542). Title compounds, 6a, 6d, 6i, 6j, 7e, 10a and 10i were found to be active against Mycobacterium tuberculosis H37Rv strain and could be lead molecules of interest.
AB - Three new series of quinoline-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines were synthesized through multi-step reactions. The required intermediate, [1-(6-methoxy-2-methylquinolin-4-yl)-1H-1, 2,3-triazol-4-yl]methanol (2) was prepared by treating 4-azido-6-methoxy-2- methylquinoline (1) with propargyl alcohol. Three different series of compounds were synthesized from this intermediate. All the newly synthesized compounds were characterized by spectral and elemental analyses. The structure of 2 was confirmed by X-ray crystallographic study. Further, the title compounds were evaluated for their in vitro anti-bacterial activity against five different bacterial strains and antimycobacterial activity against Mycobacterium tuberculosis H37Rv, Mycobacterium smegmatis (ATCC 19420) and Mycobacterium fortuitum (ATCC 19542). Title compounds, 6a, 6d, 6i, 6j, 7e, 10a and 10i were found to be active against Mycobacterium tuberculosis H37Rv strain and could be lead molecules of interest.
KW - 1,2,3-triazole
KW - Amidopiperazine
KW - Antimycobacterial
KW - Propargyl alcohol
KW - Quinoline
UR - http://www.scopus.com/inward/record.url?scp=79955643105&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955643105&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2011.03.039
DO - 10.1016/j.ejmech.2011.03.039
M3 - Article
C2 - 21489660
AN - SCOPUS:79955643105
SN - 0223-5234
VL - 46
SP - 2503
EP - 2512
JO - European journal of medicinal chemistry
JF - European journal of medicinal chemistry
IS - 6
ER -